ITCI

Intra-Cellular Therapies Inc.

Delisted

ITCI was delisted on the 1st of April, 2025.

126 hedge funds and large institutions have $498M invested in Intra-Cellular Therapies Inc. in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 46 increasing their positions, 31 reducing their positions, and 16 closing their positions.

Holders
126
Holders Change
-1
Holders Change %
-0.79%
% of All Funds
2.74%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
46
Reduced
31
Closed
16
Calls
$51.7M
Puts
$21.9M
Net Calls
+$29.8M
Net Calls Change
-$8.42M
Name Market Value Shares Shares
Change
Shares
Change %
LTFS
126
Ladenburg Thalmann Financial Services
Florida
$2K 150
CWG
127
C WorldWide Group
Denmark
-146,671 Closed
CCP
128
Clough Capital Partners
Massachusetts
-133,224 Closed
PVI
129
Pura Vida Investments
New York
-100,000 Closed
CM
130
Caption Management
Oklahoma
-80,000 Closed
TEE
131
Tibra Equities Europe
United Kingdom
-43,300 Closed
AIM
132
Assured Investment Management
New York
-40,330 Closed
SCA
133
Secor Capital Advisors
New York
-31,004 Closed
JT
134
Jump Trading
Illinois
-14,600 Closed
SG Americas Securities
135
SG Americas Securities
New York
-8,235 Closed
Walleye Capital
136
Walleye Capital
New York
-7,605 Closed
PCM
137
Prelude Capital Management
New York
-5,318 Closed
SWM
138
SeaCrest Wealth Management
New York
-3,673 Closed
CG
139
Cutler Group
California
-3,600 Closed
SEI Investments
140
SEI Investments
Pennsylvania
-2,396 Closed
DBT
141
Dubuque Bank & Trust
Iowa
-250 Closed
PCP
142
Proficio Capital Partners
Massachusetts
-29 Closed
DAM
143
DLD Asset Management
New York
SCM
144
Sio Capital Management
New York
HT
145
HAP Trading
New York
SFM
146
Sphera Funds Management
Israel
Verition Fund Management
147
Verition Fund Management
Connecticut
WAM
148
Wolverine Asset Management
Illinois
Point72 Asset Management
149
Point72 Asset Management
Connecticut
JGC
150
J. Goldman & Co
New York